Friday, 14th of March 2025
12.00 - 13.15
Registration and working lunch
13.15 - 13.30
Welcome and introduction of the think-tank's aims and deliverables
Marek Jutel, Poland and Ioana Agache, Romania
13.30 - 15.10
Session I: Rationale for targeted management of allergic diseases
Chairs: Alberto Papi, Italy and Parameswaran Nair, Canada
13.30 - 13.50
The new EAACI nomenclature of allergic diseases and hypersensitivity reactions
Marek Jutel, Poland
13.50 - 14.10
Endotype, regiotype, theratype – from bed to bedside
Ioana Agache, Romania
14.10-14.40
Precision immunology for chronic lung diseases
Ali Önder Yldirim, Germany
14.40 - 15.10
The value of biomarkers
Manali Mukherjee, Canada
15.10 - 15.45
Case study session I
Parameswaran Nair, Canada
15.45 - 16.15
Coffee break
16.15 - 18.20
Session II: Targeted asthma treatment
Chairs: Ioana Agache, Romania and Ali Önder Yldirim, Germany
16.15 - 16.45
The concept of disease remission
Alberto Papi, Italy
16.45 - 17.15
Targeted treatment for asthma - how to define response in the clinic
Parameswaran Nair, Canada
17.15 - 17.45
Small molecules for asthma and COPD
Steve Georas, USA
17.45 – 18.05
Long-term anti-IL-5 treatment for remodeling in asthma
Maciej Kupczyk, Poland
18.05 - 18.20
Management of NSAID-exacerbated respiratory disease: biologics or desensitization
Marek Sanak, Poland
18.30 - 19.30
Think-tank on “Targeted treatment in asthma – opportunities and challenges” with all participants
discussion moderated by Marek Jutel, Poland and Ioana Agache, Romania
.png)